D

DaVita
D

DVA

142.340
USD
-3.56
(-2.44%)
مغلق
حجم التداول
81,641
الربح لكل سهم
11
العائد الربحي
-
P/E
13
حجم السوق
11,387,200,000
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ABT
    ABT
    1.785
    (1.34%)
    134.950 USD
    C
    CHE
    -4.92
    (-0.89%)
    546.24 USD
    CNC
    CNC
    -0.780
    (-1.33%)
    57.690 USD
    H
    HSIC
    -0.820
    (-1.05%)
    77.255 USD
    M
    MMSI
    -2.470
    (-2.34%)
    103.150 USD
    S
    SRDX
    0.530
    (1.54%)
    34.920 USD
    T
    THO
    -1.540
    (-1.53%)
    99.000 USD
    U
    USPH
    -1.810
    (-2.10%)
    84.210 USD
    المزيد
الأخبار
المقالات

العنوان: DaVita

القطاع: Healthcare
الصناعة: Medical Care Facilities
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 250,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of the US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.